IR
Superintel
Overview
Markets
Watchlist
More
Achillion Pharma CVR
Q2 2026 vs Q3 2026
Comparing institutional holders between quarters
Quarters
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile
1
Filed
0
New
0
Closed
0
Increased
0
Decreased
1
Unchanged
0
No Data
Sort by
Q3 2026 shares — high to low
Q3 2026 shares — low to high
Share change — largest gain
Share change — largest cut
% change — largest gain
% change — largest cut
Q3 2026 value — high to low
Value change — largest gain
Value change — largest cut
Institution — A to Z
Filed — newest first
Rhumbline Advisers
UNCHANGED
Shares
35,209
from 35,209
Change
0
(0%)
Value
$0
($0)
Filed 2026-11-10
Institution
Status
Q3 2026 ↓
Q2 2026
Change
% Change
Q2 2026 Value
Q3 2026 Value
Value Change
Filed
Rhumbline Advisers
UNCHANGED
35,209
35,209
0
0%
$0
$0
$0
2026-11-10
Showing 1 of 1 institutions